ENSIGN INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating The Ensign Group, Inc. on Behalf of Ensign Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. is investigating potential claims against The Ensign Group, Inc. (“Ensign” or the “Company”) (NASDAQ:ENSG) on behalf of Ensign stockholders. Our investigation concerns whether Ensign has violated the federal securities laws and/or engaged in other unlawful business practices.

On June 8, 2026, Hunterbrook published a short report alleging that Ensign Group's business model relies on inadequate patient care and gaming quality metrics. The Hunterbrook report further alleges that Ensign Group's profits depend on understaffing facilities while routing taxpayer dollars to executives and affiliates, and that patients have suffered and died as a result. Following publication of the Hunterbrook report, Ensign Group's stock price fell $13.88 per share, or 8.15%, to close at $156.42 per share on June 8, 2026.

If you purchased or acquired stock in Ensign and would like to discuss your legal rights, contact Bragar Eagel & Squire partners Brandon Walker or Melissa Fortunato by email at [email protected] or by telephone at (212) 355-4648.